Quantcast
Channel: OneMedPlace - Sentineleli lilly
Browsing all 6 articles
Browse latest View live

http://www.onemedplace.com/blog/wp-content/uploads/2009/04/heart_monitor.jpg

Blood-thinning drug Plavix racks up over $8 billion in annual sales, but the blockbuster medication may have some new competition.

View Article



http://www.onemedplace.com/blog/wp-content/uploads/2009/07/lungs-small.jpg

Two pharmaceutical companies are eager to advance a different approach to treating lung cancer.

View Article

http://www.onemedplace.com/blog/wp-content/uploads/2009/11/diabetes.jpg

The approval of Novo Nordisk's diabetes drug Victoza has led to an unintended benefit for a competitor.

View Article

http://www.onemedplace.com/blog/wp-content/uploads/2010/03/pills_credit_card.jpg

Delcath's Percutaneous Hepatic Perfusion (PHP) technology allows physicians to deliver significantly higher doses of existing chemotherapy drugs to the liver without exposing each patient's entire body...

View Article

http://www.onemedplace.com/blog/wp-content/uploads/2010/04/assorted-capsules.jpg

Last week, the FDA unveiled its "Bad Ad" program to encourage physicians to report questionable pharmaceutical sales pitches.

View Article


http://www.onemedplace.com/blog/wp-content/uploads/2010/05/test_tubes.jpg

One of the more impressive companies at the IN3 West conference was Altea Therapeutics, an Atlanta-based clinical stage company involved in drug delivery.

View Article
Browsing all 6 articles
Browse latest View live




Latest Images